Patents
Patents for C07D 417 - Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group (62,773)
10/2006
10/24/2006US7125863 Inhibitors of dipeptidyl peptidase IV
10/24/2006US7125840 Substituted dipeptides as growth hormone secretagogues
10/24/2006CA2261848C Cell adhesion inhibitors
10/24/2006CA2252952C Substituted aminomethylphenylsulphonylureas, their preparation, and their use as herbicides and plant growth regulators
10/24/2006CA2246678C Substituted 2-aryl-1,2,4-triazine-3,5-di(thi)ones as herbicides
10/24/2006CA2223094C Phenylpyridazinones
10/24/2006CA2214752C Herbicidal or fungicidal sulphonylaminocarbonyltriazolinones with halogenated alk(en)oxy substituents
10/24/2006CA2211411C Sulphonyl amino(thio)carbonyl-1,2,4-triazolin(thi)one derivatives, the production thereof and the use thereof as herbicides
10/24/2006CA2170426C Aqueous stabilized isothiazolone blends
10/19/2006WO2006110884A2 2, 6-di (hetero) aryl -4-amido-pyrimidines as adenosine receptor antagonists
10/19/2006WO2006109846A1 Triazole derivative and the use thereof
10/19/2006WO2006109817A1 1,4-substituted piperazine derivative
10/19/2006WO2006109084A1 Dna-pk inhibitors
10/19/2006WO2006109026A1 4-(pyrid-2-yl) amino substituted pyrimidine as protein kinase inhibitors
10/19/2006WO2006108800A1 Benzimidazole derivatives and their use for modulating the gabaa receptor complex
10/19/2006WO2006108791A2 Heterocyclylethylheterocyclylcarboxamide derivatives as fungicides
10/19/2006WO2006108701A1 3- (1,2,4-triazol-3ylalkyl) azabriclo (3.1.0) hexane derivatives as modulators of dopamine d3 receptors
10/19/2006WO2006094104A3 Chemical probe compounds that become fluorescent upon reduction, and methods for their use
10/19/2006WO2005103041A3 Treatment of cns disorders using cns target modulators
10/19/2006WO2005023182A3 Nitrosated and nitrosylated cardiovascular compounds, compositions and methods of use
10/19/2006US20060235222 Indole-derivative modulators of steroid hormone nuclear receptors
10/19/2006US20060235069 Benzamide modulators of metabotropic glutamate receptors
10/19/2006US20060235061 Methods of using benzothiophenone derivatives to treat cancer or inflammation
10/19/2006US20060235054 e.g. 3-substituted 5-(4-fluorophenyl)-4-(4-pyridyl)imidazole-2-thione; immunomodulating and cytokine-release-inhibiting action; antiinflammatory agent
10/19/2006US20060235033 Quinoline derivatives and quinazoline derivatives inhibiting autophosphorylation of macrophage colony stimulating factor receptor
10/19/2006US20060235023 Inhibitors of macrophage migration inhibitory factor and methods for indentifying the same
10/19/2006US20060235022 Therapeutic agents useful for treating pain
10/19/2006US20060235021 Phenylpyridazine derivatives as ligands for gaba receptors
10/19/2006US20060235019 Substituted quinazolinone compounds
10/19/2006US20060235017 e.g. 1-Methyl-7-(pyrimidin-4-yloxy)-1H-indole-2-carboxylic acid (5-tert-butyl-3-methanesulfonylamino-2-methoxy-phenyl)-amide; antiinflammatory, antidiabetic, analgesic agent; osteoarthritis, atherosclerosis, contact dermatitis, bone resorption diseases, reperfusion injury, asthma
10/19/2006US20060235010 DNA replication that interfere with the E1-E2-DNA complex during initiation of DNA replication; 1-(hydroxy, oxo, or epoxy)-3-oxo-3'-benzaminocarbonyl-4'-(carboxy or carboxylate)-1,2,3-trihydroindene-2-spiro-2'-tetrahydrofuran derivatives
10/19/2006US20060235004 Pyrimidin-2-one compounds and their use as dopamine d3 receptor ligands
10/19/2006US20060234987 Neuroprotective benzo 1 3 oxathiol 2 ones
10/19/2006US20060234984 Mitotic kinesin inhibitors
10/19/2006CA2604773A1 Npy antagonists, preparation and use
10/19/2006CA2604516A1 Benzimidazole derivatives and their use for modulating the gabaa receptor complex
10/19/2006CA2603701A1 1,4-substituted piperazine derivative
10/19/2006CA2602721A1 4-(pyrid-2-yl) amino substituted pyrimidine as protein kinase inhibitors
10/18/2006EP1712550A2 Substituted triazole diamine derivatives as kinase inhibitors
10/18/2006EP1712548A2 5-amino-4-hydroxy-7-(pyridinylmethyl)-alkanamide derivatives and related compounds as renin inhibitors for the treatment of hypertension
10/18/2006EP1711825A2 Conjugated small molecules
10/18/2006EP1711500A1 Diaza- or thiazadione derivatives with neuroprotective activity
10/18/2006EP1711497A1 2-(3-substituted-aryl)amino-4-aryl-thiazoles as tyrosine kinase inhibitors
10/18/2006EP1711496A1 Thiazole compounds
10/18/2006EP1711495A2 Quinoline, quinazoline, pyridine and pyrimidine counds and their use in the treatment of inflammation, angiogenesis and cancer
10/18/2006EP1711494A1 Aryl substituted heterocycles, method for production and use thereof as medicaments
10/18/2006EP1711491A1 Heterocyclic derivatives as gpcr receptor agonists
10/18/2006EP1711481A2 Process for preparing 2-aminothiazole-5-aromatic carboxamides as kinase inhibitors
10/18/2006EP1711184A1 (3-oxo-3,4-dihydro-quinoxalin-2-yl-amino)-benzamide derivatives and related compounds as glycogen phosphorylase inhibitors for the treatment of diabetes and obesity
10/18/2006EP1711180A1 Thiazolylimidazole derivatives and their use as inhibitors of microsomal triglyceride transfer protein
10/18/2006EP1366046B1 Monomer for use in preparation of a polymer to be used in optical devices
10/18/2006CN1849321A Hetaryl-substituted pyrazolidindione derivatives with pesticidal characteristics
10/18/2006CN1849318A Methods of treating or preventing autoimmune diseases with 2, 4-pyrimidinediamine compounds
10/18/2006CN1849310A Thiazole derivatives as cannabinoid receptor modulators
10/18/2006CN1849302A 1, 3-disubstituted azetidine derivatives for use as CCR-3 receptor antagonists in the treatment of inflammatory and allergic diseases
10/18/2006CN1849120A 17-heterocyclic-4-azasteroid derivatives as androgen receptor modulators
10/18/2006CN1280279C Dibenzo-isozaolone compounds and their synthesis process and application
10/18/2006CN1280277C Diamide invertebrate pest control agents contg. non-aromatic heterocyclic ring
10/18/2006CN1280269C Aliphatic nitrogenous five-membered ring compounds
10/17/2006USRE39356 Macrolactamization; deesterification, coupling decyclization, catalysis; one pot process; anticarcinogenic and antiproliferative agents
10/17/2006US7122565 Thiadiazoles and oxadiazoles and their use as phosphodiesterase-7 inhibitors
10/17/2006US7122564 Biaromatic ligand activators of PPARγ receptors
10/17/2006US7122559 Useful as anticoagulants in therapy and prophylaxis of cardiovascular diseases, as anti-inflammatory agents, and as metastasis inhibitors in therapy of cancer
10/17/2006US7122547 Anthranilic acid amides and the use thereof as medicaments
10/17/2006US7122546 GABAA (gamma-aminobutyric acid) receptor modulators; anxiolytic, antidepresant agents; attention deficit disorder, Alzheimer*s disease treatment; central nervous systmem disorders
10/17/2006US7122545 Imidazo-benzothiazoles
10/17/2006US7122544 Anilinopyrimidine derivatives as IKK inhibitors and compositions and methods related thereto
10/17/2006US7122542 Methods of treating or preventing autoimmune diseases with 2,4-pyrimidinediamine compounds
10/17/2006US7122538 Neuroleptic agents for treating schizophrenia, psychological disorders, depression; 5-(4-Chlorophenyl)-thiophene-2-sulfonic acid (8-methoxy-3-methyl-2,3,4,5-tetrahydro-1H-benzo[d]azepin-7-yl)amide
10/17/2006US7122535 For treating pain in a warm-blooded animal; enzyme inhibitor on NO-synthase enzymes; STROKE, NEURODEGENERATIVE DISEASES, ISCHEMIC OR HEMORRAGIC CARDIAC OR CEREBRAL INFARCTIONS
10/17/2006US7121707 Illuminated electrical cords and outlets
10/17/2006CA2238818C 1-(1,2-disubstituted piperidinyl)-4-substituted piperidine derivatives as tachykinin receptor antagonists
10/17/2006CA2238817C 1-(1,2-disubstituted piperidinyl)-4-(fused imidazole)-piperidine derivatives
10/12/2006WO2006108107A1 Diarylamine-containing compounds and compositions, and their use as modulators of steroid hormone nuclear receptors
10/12/2006WO2006106812A1 Propane-1,3-dion derivative or salt thereof
10/12/2006WO2006106778A1 Bcrp/abcg2 inhibitor
10/12/2006WO2006106425A1 Bicyclic [3.1.0] heteroaryl amides as type i glycine transport inhibitors
10/12/2006WO2006105979A1 Sulfonylpyrroles as histone deacetylase inhibitors
10/12/2006WO2005123703A3 Alkynyl derivatives as modulators of metabotropic glutamate receptors
10/12/2006US20060229453 Process for the preparation of 5-[4-[2-[N-methyl-N-(2-pyridyl) amino] ethoxy] phenyl methyl] thiazolidine-2,4-dione maleate (rosiglitazone)
10/12/2006US20060229445 Organic compounds
10/12/2006US20060229343 Pyrrolidine oxadiazole-and thiadiazole oxime derivatives being oxytocin receptor antagonists
10/12/2006US20060229342 TNF-a production inhibitors
10/12/2006US20060229335 Diarylamine and arylheteroarylamine pyrazole derivatives as modulators of 5ht2a
10/12/2006US20060229325 Cancer therapy, auto-immune diseases, such as psoriasis, alopecia and multiple sclerosis; chemotherapy agent-induced alopecia and mucositis; cardiovascular diseases, such as stenoses, arterioscieroses and restenoses; infectious diseases, such as, e.g., those caused by unicellular parasites
10/12/2006US20060229317 Substituted heterocyclic compounds
10/12/2006US20060229315 3-Substituted Quinoline-4-Carboxamide Derivatives as NK-3 and NK-2 Receptor Antagonists
10/12/2006US20060229312 Quinoline and quinazoline derivatives having affinity for 5ht1-type receptors
10/12/2006US20060229311 Isatine derivatives with neurotrophic activity
10/12/2006US20060229294 Benzisothiazoles useful for treating or preventing HCV infection
10/12/2006US20060229205 Herbicidal heterocycles
10/12/2006CA2603939A1 Bicyclic [3.1.0] heteroaryl amides as type i glycine transport inhibitors
10/12/2006CA2603826A1 Substituted oxazole derivatives and their use as tyrosine kinase inhibitors
10/12/2006CA2603398A1 Sulfonylpyrroles as histone deacetylase inhibitors
10/12/2006CA2603250A1 Diarylamine-containing compounds and compositions, and their use as modulators of steroid hormone nuclear receptors
10/12/2006CA2602467A1 Bcrp/abcg2 inhibitor
10/11/2006EP1710793A1 Metal chelate compounds and high capacity optical recording medium using the compounds
10/11/2006EP1710238A1 Benzophenones as inhibitors of reverse transcriptase
10/11/2006EP1709041A1 Acylaminothiazole derivatives, preparation method thereof and use of same in therapeutics
10/11/2006EP1709040A2 Five-membered heterocyclic compounds as inhibitors of src family protein kinase